Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 9/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.64 |
| ▸ | MAPT | P10636 | 4/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.64 |
| ▸ | MEN1 | O00255 | 3/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.64 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.64 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.64 |
| ▸ | AR | P10275 | 2/20 | 0.63 |
| ▸ | MAOB | P27338 | 2/20 | 0.59 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.59 |
| ▸ | MAOA | P21397 | 1/20 | 0.59 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL349721 | 0.91 | CYP19A1 (0.62) | CYP19A1CYP3A4MAPTHSD17B10MEN1 | |
| SCHEMBL27860085 | 0.88 | CYP19A1 (0.51) | CYP19A1CYP3A4MAPTHSD17B10MEN1 | |
| SCHEMBL2781916 | 0.86 | MAPT (0.71) | CYP19A1CYP3A4MAPTHSD17B10MEN1 | |
| SCHEMBL15544304 | 0.85 | MAPT (0.55) | CYP19A1CYP3A4MAPTHSD17B10MEN1 | |
| SCHEMBL5084282 | 0.85 | ABCG2 (0.68) | CYP19A1CYP3A4MAPTHSD17B10MEN1 | |
| SCHEMBL17318042 | 0.84 | CYP1A1 (0.67) | CYP19A1CYP3A4MAPTCYP1A1CYP1A2 | |
| SCHEMBL7200859 | 0.84 | CYP1A1 (0.67) | CYP19A1CYP3A4MAPTCYP1A1CYP1A2 | |
| SCHEMBL3364494 | 0.82 | MEN1 (0.65) | CYP19A1CYP3A4MAPTHSD17B10MEN1 | |
| SCHEMBL130267 | 0.82 | CYP19A1 (0.59) | CYP19A1CYP3A4MAPTHSD17B10MEN1 | |
| SCHEMBL9205670 | 0.82 | CYP19A1 (0.59) | CYP19A1CYP3A4MAPTHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260102359-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | ERESINA LLC (US) | 2026-04-16 | — | — | US | claimed |
| EP-4593859-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | Eresina, LLC (US) | 2025-08-06 | — | — | EP | claimed |
| WO-2024073013-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | ERESINA, LLC (US) | 2024-04-04 | — | — | WO | claimed |
| WO-2024073011-A1 | TOPICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | ERESINA, LLC (US) | 2024-04-04 | — | — | WO | claimed |
| CN-115928318-A | Preparation method of antibacterial and antiviral packaging material and packaging material using same | 华南农业大学 | 2023-04-07 | — | — | CN | claimed |
| US-11596657-B2 | Use of AhR agonist for the preventive or curative treatment of metabolic syndrome and the associated disorders | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 2023-03-07 | — | — | US | claimed |
| US-20190282638-A1 | USE OF AHR AGONIST FOR THE PREVENTIVE OR CURATIVE TREATMENT OF METABOLIC SYNDROME AND THE ASSOCIATED DISORDERS | INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (FR) | 2019-09-19 | — | — | US | claimed |
| EP-3522902-A1 | USE OF AHR AGONIST FOR THE PREVENTIVE OR CURATIVE TREATMENT OF METABOLIC SYNDROME AND THE ASSOCIATED DISORDERS | Institut National de la Recherche Agronomique (FR) | 2019-08-14 | — | — | EP | claimed |
| WO-2018065132-A1 | USE OF AHR AGONIST FOR THE PREVENTIVE OR CURATIVE TREATMENT OF METABOLIC SYNDROME AND THE ASSOCIATED DISORDERS. | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 2018-04-12 | — | — | WO | claimed |
| EP-1067913-B1 | COMPOSITIONS AND METHODS OF ADJUSTING STEROID HORMONE METABOLISM THROUGH FACILITATED ABSORPTION OF HYDROPHOBIC DIETARY COMPOUNDS | BIORESPONSE LLC (US) | 2012-08-29 | — | — | EP | claimed |
| EP-1893173-B1 | AMINO-OXO-INDOLE-YLIDENE COMPOUNDS FOR USE IN TREATING SCALP SKIN ITCHING | UNILEVER PLC (GB) | 2010-10-06 | — | — | EP | claimed |
| EP-1067913-A4 | COMPOSITIONS AND METHODS OF ADJUSTING STEROID HORMONE METABOLISM THROUGH FACILITATED ABSORPTION OF HYDROPHOBIC DIETARY COMPOUNDS | BIORESPONSE LLC (US) | 2009-03-11 | — | — | EP | claimed |
| US-20080207928-A1 | Hair and/or Scalp Care Compositions Incorporating Flavonoid Compounds | CONOPCO, INC. D/B/A UNILEVER | 2008-08-28 | — | — | US | claimed |
| EP-1893173-A1 | HAIR AND/OR SCALP CARE COMPOSITIONS INCORPORATING AMINO-OXO-INDOLE-YLIDENE COMPOUNDS | Unilever Plc (GB) | 2008-03-05 | — | — | EP | claimed |
| WO-2006097191-A1 | HAIR AND/OR SCALP CARE COMPOSITIONS INCORPORATING FLAVONOID COMPOUNDS | UNILEVER PLC (GB) | 2006-09-21 | — | — | WO | claimed |
| EP-1067913-A1 | COMPOSITIONS AND METHODS OF ADJUSTING STEROID HORMONE METABOLISM THROUGH FACILITATED ABSORPTION OF HYDROPHOBIC DIETARY COMPOUNDS | Bioresponse, L.L.C. (US) | 2001-01-17 | — | — | EP | claimed |
| US-6086915-A | HEATING THE SOLUBILIZING EMULSIFIER, ADDING SOLVENT AND ONE OR MORE PHOSPHOLIPID SURFACTANTS, DISSOLVING IN THIS SOLUTION ONE OR MORE HYDROPHOBIC PHYTOCHEMICALS, ADDING ENCAPSULATORS, FORMING MICROEMULSION, SPRAY DRYING THE SOLUTION | BIORESPONSE L.L.C. (US) | 2000-07-11 | — | — | US | claimed |
| WO-1999049851-A1 | COMPOSITIONS AND METHODS OF ADJUSTING STEROID HORMONE METABOLISM THROUGH FACILITATED ABSORPTION OF HYDROPHOBIC DIETARY COMPOUNDS | BIORESPONSE, L.L.C. (US) | 1999-10-07 | — | — | WO | claimed |
| US-4617293-A | Flavonoid phosphate salts of aminoglycoside antibiotics | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1986-10-14 | — | — | US | claimed |
| US-20260102359-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | ERESINA LLC (US) | 2026-04-16 | — | — | US | disclosed |
| EP-3522902-B1 | PROBIOTIC BACTERIA PRODUCING AN AHR AGONIST AND THEIR USE IN THE TREATMENT OF METABOLIC SYNDROME AND OBESITY | INSTITUT NATIONAL DE RECH POUR LAGRICULTURE LALIMENTATION ET LENVIRONNEMENT (FR) | 2025-09-03 | — | — | EP | disclosed |
| EP-4593859-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | Eresina, LLC (US) | 2025-08-06 | — | — | EP | disclosed |
| US-20240316118-A1 | ANTIVIRAL NASAL SPRAY FLAVONOIDS?BEE PROPOLIS | MCCAFFREY STEPHEN MARK (AU) | 2024-09-26 | — | — | US | disclosed |
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | disclosed |
| CN-115850225-B | Application of hesperidin and method for semisynthesis preparation of chrysin by using hesperidin derivative | 三原润禾生物科技有限公司 | 2024-06-28 | — | — | CN | disclosed |
| WO-2024073013-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | ERESINA, LLC (US) | 2024-04-04 | — | — | WO | disclosed |
| WO-2024073011-A1 | TOPICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | ERESINA, LLC (US) | 2024-04-04 | — | — | WO | disclosed |
| US-20230152314-A1 | LIPOCALIN-2 ASSAY FOR INTESTINAL ADAPTATION | THE JOHNS HOPKINS UNIVERSITY | 2023-05-18 | — | — | US | disclosed |
| CN-116077532-A | Nasal spray formulation, method for producing the same and use thereof | 艾琳·杰玛·艾丽西娅·梅耶斯 | 2023-05-09 | — | — | CN | disclosed |
| CN-115928318-A | Preparation method of antibacterial and antiviral packaging material and packaging material using same | 华南农业大学 | 2023-04-07 | — | — | CN | disclosed |
| US-20230095683-A1 | COPROCOCCUS BACTERIA FOR USE IN THE TREATMENT OF METABOLIC SYNDROME AND INFLAMMATORY BOWEL DISEASES | SORBONNE UNIVERSITE (FR) | 2023-03-30 | — | — | US | disclosed |
| CN-115850225-A | Application of hesperidin and method for semi-synthesizing chrysin by using hesperidin derivative | 三原润禾生物科技有限公司 | 2023-03-28 | — | — | CN | disclosed |
| US-11596657-B2 | Use of AhR agonist for the preventive or curative treatment of metabolic syndrome and the associated disorders | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 2023-03-07 | — | — | US | disclosed |
| EP-4114420-A1 | COPROCOCCUS BACTERIA FOR USE IN THE TREATMENT OF METABOLIC SYNDROME AND INFLAMMATORY BOWEL DISEASES | Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (FR) | 2023-01-11 | — | — | EP | disclosed |
| WO-2022160018-A1 | ANTIVIRAL NASAL SPRAY | MCCAFFREY, Stephen, Mark (AU) | 2022-08-04 | — | — | WO | disclosed |
| WO-2021175998-A1 | COPROCOCCUS BACTERIA FOR USE IN THE TREATMENT OF METABOLIC SYNDROME AND INFLAMMATORY BOWEL DISEASES | INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (FR) | 2021-09-10 | — | — | WO | disclosed |
| EP-3875098-A1 | USE OF COPROCOCCUS BACTERIA FOR THE TREATMENT OF METABOLIC SYNDROME AND INFLAMMATORY BOWEL DISEASES | INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (FR) | 2021-09-08 | — | — | EP | disclosed |
| US-10881700-B1 | Compositions including extracts of gray mangrove leaves and methods of treatment using such compositions in treatment of viral infections | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2021-01-05 | — | — | US | disclosed |
| US-20190282638-A1 | USE OF AHR AGONIST FOR THE PREVENTIVE OR CURATIVE TREATMENT OF METABOLIC SYNDROME AND THE ASSOCIATED DISORDERS | INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (FR) | 2019-09-19 | — | — | US | disclosed |
| EP-3522902-A1 | USE OF AHR AGONIST FOR THE PREVENTIVE OR CURATIVE TREATMENT OF METABOLIC SYNDROME AND THE ASSOCIATED DISORDERS | Institut National de la Recherche Agronomique (FR) | 2019-08-14 | — | — | EP | disclosed |
| US-9949946-B2 | Inclusion complexes of pinocembrin with cyclodextrin or its derivatives | CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD. (CN) | 2018-04-24 | — | — | US | disclosed |
| WO-2018065132-A1 | USE OF AHR AGONIST FOR THE PREVENTIVE OR CURATIVE TREATMENT OF METABOLIC SYNDROME AND THE ASSOCIATED DISORDERS. | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 2018-04-12 | — | — | WO | disclosed |
| US-9757378-B2 | Methods to modulate acute myeloid leukemia stem/progenitor cell expansion and/or differentiation | UNIVERSITE DE MONTREAL (CA) | 2017-09-12 | — | — | US | disclosed |
| CN-105884736-A | Method for separating and preparing 5 flavonoid compounds from Oxytropis falcate Bunge | 中国科学院西北高原生物研究所 | 2016-08-24 | — | — | CN | disclosed |
| CN-105796548-A | Flavonoid drug composition and preparation method and application | 中国科学院西北高原生物研究所 | 2016-07-27 | — | — | CN | disclosed |
| CN-102988279-B | Pinocembrin and cyclodextrin super molecule inclusion compound and its preparation method | 石药集团中奇制药技术（石家庄）有限公司 | 2016-06-15 | — | — | CN | disclosed |
| CN-103308637-B | Gas chromatography-mass spectrometry method for identifying dalbergia odorifera and dalbergia tonkinensi | ZHEJIANG FORESTRY PRODUCT TEST STATION | 2014-11-26 | — | — | CN | disclosed |
| US-20140343051-A1 | METHODS TO MODULATE ACUTE MYELOID LEUKEMIA STEM/PROGENITOR CELL EXPANSION AND/OR DIFFERENTIATION | HOPITAL MAISONNEUVE-ROSEMONT (CA) | 2014-11-20 | — | — | US | disclosed |
| CN-103308637-A | Gas chromatography-mass spectrometry method for identifying dalbergia odorifera and dalbergia tonkinensi | ZHEJIANG FOREST PRODUCTS QUALITY INSPECTION STATION | 2013-09-18 | — | — | CN | disclosed |
| EP-2359861-B1 | INCLUSION COMPLEXES OF PINOCEMBRIN WITH CYCLODEXTRIN OR ITS DERIVATIVES | CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY SHIJIAZHUANG CO LTD (CN) | 2013-09-11 | — | — | EP | disclosed |
| CN-102988279-A | Pinocembrin and cyclodextrin supermolecular inclusion complex and preparation method thereof | CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY SHIJIAZHUANG CO LTD | 2013-03-27 | — | — | CN | disclosed |
| CN-102716070-A | Pinocembrin and cyclodextrin or cyclodextrin derivative clathrate compound | INST MATERIA MEDICA CAMS | 2012-10-10 | — | — | CN | disclosed |
| EP-1067913-B1 | COMPOSITIONS AND METHODS OF ADJUSTING STEROID HORMONE METABOLISM THROUGH FACILITATED ABSORPTION OF HYDROPHOBIC DIETARY COMPOUNDS | BIORESPONSE LLC (US) | 2012-08-29 | — | — | EP | disclosed |
| CN-101537188-B | Pinocembrin cyclodextrin or cyclodextrin derivative clathrate | INST MATERIA MEDICA CAMS | 2012-07-18 | — | — | CN | disclosed |
| EP-2377529-A1 | USE OF RACEMATES OF PINOCEMBRIN IN PREPARING MEDICAMENTS FOR TREATING STROKE | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. (CN) | 2011-10-19 | — | — | EP | disclosed |
| US-20110245334-A1 | USE OF RACEMATES OF PINOCEMBRIN IN PREPARING MEDICAMENTS FOR TREATING STROKE | CSPC Zhonggi Pharmaceutical Technology (Shijiazhuang) Co. Ltd. (CN) | 2011-10-06 | — | — | US | disclosed |
| US-20110218173-A1 | INCLUSION COMPLEXES OF PINOCEMBRIN WITH CYCLODEXTRIN OR ITS DERIVATIVES | SHANDONG XINHUA PHARMACEUTICAL CO., LTD. (CN) | 2011-09-08 | — | — | US | disclosed |
| EP-2359861-A1 | INCLUSION COMPLEXES OF PINOCEMBRIN WITH CYCLODEXTRIN OR ITS DERIVATIVES | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. (CN) | 2011-08-24 | — | — | EP | disclosed |
| EP-1738781-B1 | Use of propolis for coating medical implants | BIOTRONIK VI PATENT AG (CH) | 2011-03-16 | — | — | EP | disclosed |
| EP-1893173-B1 | AMINO-OXO-INDOLE-YLIDENE COMPOUNDS FOR USE IN TREATING SCALP SKIN ITCHING | UNILEVER PLC (GB) | 2010-10-06 | — | — | EP | disclosed |
| CN-101537188-A | Pinocembrin cyclodextrin or cyclodextrin derivative clathrate | INST MATERIA MEDICA CAMS | 2009-09-23 | — | — | CN | disclosed |
| EP-2082726-A2 | Hair and/or scalp care compositions incorporating flavonoid compounds | Unilever PLC (GB) | 2009-07-29 | — | — | EP | disclosed |
| US-20080207928-A1 | Hair and/or Scalp Care Compositions Incorporating Flavonoid Compounds | CONOPCO, INC. D/B/A UNILEVER | 2008-08-28 | — | — | US | disclosed |
| WO-2007115181-A9 | COMPOUNDS EXHIBITING EFFLUX INHIBITOR ACTIVITY AND COMPOSITIONS AND USES THEREOF | EASTMAN CHEM CO (US) | 2008-04-03 | — | — | WO | disclosed |
| EP-1893173-A1 | HAIR AND/OR SCALP CARE COMPOSITIONS INCORPORATING AMINO-OXO-INDOLE-YLIDENE COMPOUNDS | Unilever Plc (GB) | 2008-03-05 | — | — | EP | disclosed |
| WO-2007115181-A2 | COMPOUNDS EXHIBITING EFFLUX INHIBITOR ACTIVITY AND COMPOSITIONS AND USES THEREOF | EASTMAN CHEMICAL COMPANY (US) | 2007-10-11 | — | — | WO | disclosed |
| EP-1738781-A2 | Use of propolis for coating medical implants | BIOTRONIK VI Patent AG (CH) | 2007-01-03 | — | — | EP | disclosed |
| WO-2006097191-A1 | HAIR AND/OR SCALP CARE COMPOSITIONS INCORPORATING FLAVONOID COMPOUNDS | UNILEVER PLC (GB) | 2006-09-21 | — | — | WO | disclosed |
| WO-2006030322-A2 | USE OF FLA VONE/FLA VANONE DERIVATIVES FN THE TREATMENT OR PREVENTION OF RESPIRATORY CONDITIONS | UNIVERSITY OF MANITOBA (CA) | 2006-03-23 | — | — | WO | disclosed |
| EP-1436371-A2 | ENZYMATIC SYSTEMS FOR GENERATING ACTIVE OXYGEN SPECIES FOR REACTING WITH OTHER PRECURSORS TO OBTAIN OXIDATION AND/OR BLEACHING | Call, Krimhild (DE) | 2004-07-14 | — | — | EP | disclosed |
| EP-1286706-A2 | GAMMA IRRADIATION OF PROTEIN-BASED PHARMACEUTICAL PRODUCTS | The American National Red Cross (US) | 2003-03-05 | — | — | EP | disclosed |
| WO-2002099023-A2 | ENZYMATIC SYSTEMS FOR GENERATING ACTIVE OXYGEN SPECIES FOR REACTING WITH OTHER PRECURSORS TO OBTAIN OXIDATION AND/OR BLEACHING | CALL, KRIMHILD (DE) | 2002-12-12 | — | — | WO | disclosed |
| WO-2001087357-A2 | GAMMA IRRADIATION OF PROTEIN-BASED PHARMACEUTICAL PRODUCTS | THE AMERICAN NATIONAL RED CROSS (US) | 2001-11-22 | — | — | WO | disclosed |
| US-6086915-A | HEATING THE SOLUBILIZING EMULSIFIER, ADDING SOLVENT AND ONE OR MORE PHOSPHOLIPID SURFACTANTS, DISSOLVING IN THIS SOLUTION ONE OR MORE HYDROPHOBIC PHYTOCHEMICALS, ADDING ENCAPSULATORS, FORMING MICROEMULSION, SPRAY DRYING THE SOLUTION | BIORESPONSE L.L.C. (US) | 2000-07-11 | — | — | US | disclosed |
| EP-1012376-A2 | OXIDATION AND BLEACHING SYSTEM WITH ENZYMATICALLY PRODUCED OXIDIZING AGENTS | Blume, Hildegard (DE) | 2000-06-28 | — | — | EP | disclosed |
| WO-1999001607-A2 | ENZYMATIC OXIDATION SYSTEM WITH NOVEL ENZYMATIC-EFFECT ENHANCING COMPOUNDS | CALL, KRIMHILD (DE) | 1999-01-14 | — | — | WO | disclosed |
| WO-1998059108-A2 | OXIDATION AND BLEACHING SYSTEM WITH ENZYMATICALLY PRODUCED OXIDIZING AGENTS | BLUME, HILDEGARD (DE) | 1998-12-30 | — | — | WO | disclosed |
| US-4617293-A | Flavonoid phosphate salts of aminoglycoside antibiotics | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1986-10-14 | — | — | US | disclosed |
| EP-0065123-B1 | HARDLY SOLUBLE SALTS OF AMINOGLYCOSIDE ANTIBIOTICS | MERCK PATENT GmbH (DE) | 1984-07-25 | — | — | EP | disclosed |
| EP-0065123-A1 | Hardly soluble salts of aminoglycoside antibiotics | MERCK PATENT GmbH (DE) | 1982-11-24 | — | — | EP | disclosed |
| EP-0065123-A1 | Hardly soluble salts of aminoglycoside antibiotics | MERCK PATENT GmbH (DE) | 1982-11-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140343051-A1 | METHODS TO MODULATE ACUTE MYELOID LEUKEMIA STEM/PROGENITOR CELL EXPANSION AND/OR DIFFERENTIATION | MCL1, AHR, MYADM | CYP19A1 86/4885CYP3A4 332/4885MAPT 4855/4885 |
| US-20110245334-A1 | USE OF RACEMATES OF PINOCEMBRIN IN PREPARING MEDICAMENTS FOR TREATING STROKE | CROCC, PNN, ZMPSTE24 | CYP19A1 4674/4885CYP3A4 1698/4885MAPT 1295/4885 |
| US-20260102359-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | COL2A1, COLGALT1, PLOD3 | CYP19A1 3685/4885CYP3A4 3867/4885MAPT 696/4885 |
| US-20080207928-A1 | Hair and/or Scalp Care Compositions Incorporating Flavonoid Compounds | POLR1C, F3, AKR1C3 | CYP19A1 25/4885CYP3A4 168/4885MAPT 2140/4885 |
| US-20110218173-A1 | INCLUSION COMPLEXES OF PINOCEMBRIN WITH CYCLODEXTRIN OR ITS DERIVATIVES | PICALM, CROCC, MPI | CYP19A1 3455/4885CYP3A4 401/4885MAPT 519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.